Karyopharm preclinical data

In BCR-ABL tyrosine kinase-positive leukemic mice, KPT-330 led to a 50% survival rate. Additionally, KPT-330 triggered apoptosis and impaired clonogenic potential of leukemic but not normal CD34-posit...